Expression of Tumour-Associated MUC1 Is a Poor Prognostic Marker in Breast Cancer in Kumasi, Ghana

Table 3

Immunohistochemical characteristics of the cases.

Biomarker	Frequency	Percent
ER
Positive	54	29.0
Negative	132	71.0
PR
Positive	20	10.9
Negative	163	89.1
HER2
Positive	37	20.7
Negative	142	79.3
MUC1
Positive	102	59.0
Negative	71	41.0
Ki-67
Low	113	62.1
Moderate	30	16.5
High	39	21.4
Cyclin D
Positive	81	44.8
Negative	100	55.2
Molecular subtype
Luminal A	32	19.8
Luminal B	16	9.9
HER2 overexpression	26	16.0
Triple negative	88	54.4